Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD

Levomecor Inc. · 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
depressionmajor-depressive-disorder
major depressive disorder, depression, rel-1017, esmethadone, relmada, antidepressant, adjunctive, nmda receptor antagonist, relight, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1009042
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.